angiotensin ii has been researched along with Weight Loss in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinugawa, S | 1 |
| Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M | 1 |
| Endo, K; Koide, N; Miyashita, Y; Murano, T; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Watanabe, H | 1 |
| Hintze, TH; Kaley, G; Kaminski, PM; Ojaimi, C; Recchia, FA; Skayian, Y; Suematsu, N; Sun, D; Wang, Z; Wolin, MS; Xu, X; Zhang, S | 1 |
| Batifoulier-Yiannikouris, F; Cassis, LA; Daugherty, A; Police, SB; Putnam, K; Thatcher, S | 1 |
| Furuya, M; Inomata, N; Kangawa, K; Minamitake, Y; Ohsuye, K; Sugiyama, M; Yamaki, A | 1 |
| Archer, DT; Fraser, SM; Merson, SJ; Shirreffs, SM | 1 |
| Barinas-Mitchell, E; Cottam, DR; Eid, G; Kelley, DE; Kuller, L; Mattar, SG; Schauer, PR | 1 |
| Böhnke, J; Engeli, S; Ghose, N; Gorzelniak, K; Janke, J; Lindschau, C; Luft, FC; Sharma, AM | 1 |
| de Resende, MM; Greene, AS; Kriegel, AJ | 1 |
| Brink, M; Delafontaine, P; Wellen, J | 1 |
| Kotchen, TA | 1 |
| Allender, PS; Cook, NR; Cutler, JA; Hennekens, CH; Hunt, SC; Oberman, A; Walker, WG; Whelton, PK; Williams, RR | 1 |
| Blanton, CA; Blevins, JE; Hamilton, JS; Hernandez, EJ; Horwitz, BA; McDonald, RB | 1 |
2 review(s) available for angiotensin ii and Weight Loss
| Article | Year |
|---|---|
Angiotensin II and skeletal muscle abnormalities.
Topics: Angiotensin I; Angiotensin II; Animals; Chronic Disease; Exercise; Humans; Muscle, Skeletal; Weight Loss | 2017 |
The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.
Topics: Acute-Phase Proteins; Adipose Tissue; Angiotensin II; Angiotensinogen; C-Reactive Protein; Humans; Inflammation; Insulin Resistance; Interleukin-6; Liver; Lymphotoxin-alpha; Morbidity; Obesity; Tumor Necrosis Factor-alpha; Weight Loss | 2004 |
1 trial(s) available for angiotensin ii and Weight Loss
| Article | Year |
|---|---|
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.
Topics: Adult; Angiotensin II; Blood Pressure; Diet, Sodium-Restricted; Female; Genotype; Humans; Hypertension; Incidence; Male; Middle Aged; Promoter Regions, Genetic; Sodium, Dietary; United States; Weight Loss | 1998 |
11 other study(ies) available for angiotensin ii and Weight Loss
| Article | Year |
|---|---|
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss | 2015 |
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Leptin; Lipoprotein Lipase; Male; Middle Aged; Obesity; Tomography, X-Ray Computed; Weight Loss | 2009 |
Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart.
Topics: Acetophenones; Angiotensin II; Animals; Ascorbic Acid; Coronary Vessels; Diet, Sodium-Restricted; Dogs; Fatty Acids; Gene Expression Profiling; Glucose; Hemodynamics; Infusions, Intravenous; Lactates; Male; Myocardium; NADPH Oxidases; Nitric Oxide; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Oxygen Consumption; Renin-Angiotensin System; Superoxides; Vasodilation; Veratrine; Weight Loss | 2010 |
Weight loss in obese C57BL/6 mice limits adventitial expansion of established angiotensin II-induced abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Connective Tissue; Dietary Fats; Disease Models, Animal; Disease Progression; Endoglin; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Obesity; RNA, Messenger; Weight Loss | 2010 |
Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
Topics: Adiposity; Angiotensin II; Animals; Cachexia; Cell Line; Feeding Behavior; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Ghrelin; Humans; Insulin-Like Growth Factor I; Mice; Muscle Cells; Muscle Proteins; Muscle, Skeletal; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Weight Loss | 2012 |
The effects of fluid restriction on hydration status and subjective feelings in man.
Topics: Adult; Angiotensin II; Attention; Blood Volume; Chlorides; Dehydration; Drinking; Female; Humans; Hunger; Male; Osmolar Concentration; Sodium; Thirst; Urine; Water Deprivation; Weight Loss | 2004 |
Regulation of the nitric oxide system in human adipose tissue.
Topics: Adipocytes; Adipose Tissue; Adult; Angiotensin II; Cells, Cultured; Female; Humans; In Vitro Techniques; Insulin; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Obesity; Weight Loss | 2004 |
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Injections, Subcutaneous; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred Strains; Spironolactone; Ventricular Function, Left; Weight Loss | 2006 |
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Hematocrit; Hydralazine; Hypertension; Imidazoles; Infusions, Intravenous; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor I; Losartan; Male; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Reference Values; Tetrazoles; Time Factors; Vasodilator Agents; Weight Loss | 1996 |
Angiotensinogen genotype and blood pressure responses to reduced dietary NaCl and to weight loss.
Topics: Adult; Angiotensin II; Animals; Blood Pressure; Diet, Sodium-Restricted; Genotype; Humans; Hypertension; Sodium Chloride, Dietary; Weight Loss | 1998 |
Reduced feeding response to neuropeptide Y in senescent Fischer 344 rats.
Topics: Aging; Angiotensin II; Animals; Body Weight; Cerebral Ventricles; Dose-Response Relationship, Drug; Energy Intake; Feeding Behavior; Humans; Injections, Intraventricular; Male; Neuropeptide Y; Rats; Rats, Inbred F344; Time Factors; Weight Gain; Weight Loss | 2001 |